1. Home
  2. CRESY vs DNA Comparison

CRESY vs DNA Comparison

Compare CRESY & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

SELL

Current Price

$10.74

Market Cap

804.3M

Sector

Finance

ML Signal

SELL

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

SELL

Current Price

$9.95

Market Cap

835.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CRESY
DNA
Founded
1936
2008
Country
Argentina
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
804.3M
835.7M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
CRESY
DNA
Price
$10.74
$9.95
Analyst Decision
Buy
Sell
Analyst Count
2
3
Target Price
★ $15.86
$8.00
AVG Volume (30 Days)
206.5K
★ 3.3M
Earning Date
11-09-2026
11-09-2026
Dividend Yield
★ 5.32%
N/A
EPS Growth
N/A
★ 46.49
EPS
★ N/A
N/A
Revenue
N/A
★ $170,155,000.00
Revenue This Year
$14.96
N/A
Revenue Next Year
$19.02
$13.05
P/E Ratio
$6.92
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$10.26
$5.37
52 Week High
$14.21
$18.22

Technical Indicators

Market Signals
Indicator
CRESY
DNA
Relative Strength Index (RSI) 38.74 47.32
Support Level $10.52 $6.54
Resistance Level $11.74 $11.12
Average True Range (ATR) 0.42 0.98
MACD -0.07 -0.38
Stochastic Oscillator 19.21 13.32

Price Performance

Historical Comparison
CRESY
DNA

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: